Startup "Day Two" has raised $ 37 million to continue developing technologies and products to improve the health of people

Posted on May 31, 2021 by Ifi Reporter

Startup "DayTwo" has raised $ 37 million to continue developing technologies and products to improve the health of people with diabetes in particular and metabolic diseases in general. The existing DayTwo investors who participated in the current round - including Marius Nacht's aMoon and Dr. Yair Schindel, Yahel Zilka's 10D and Cathay Ventures, who significantly expanded their investment, were joined by new investors - including Poalim Capital Markets, the La'maison Fund and - Micron Ventures The current round raises the capital invested in the company so far to $ 85 million.

The capital raised will be used to further increase the development center in Israel and significantly expand the company's business operations in the United States, the company's main market. The company's first product, which already serves more than 70,000 users in Israel and the United States, is based on groundbreaking research and technology developed at the Weizmann Institute by Prof. Eran Segal and Prof. Eran Elinav. The product is based on the use of artificial intelligence (AI), DNA flooring of intestinal bacteria (microbiome), medical information and personal behavioral information to individually tailor each user the diet (precision nutrition) in order to balance blood sugar levels after a meal.
"Over the past year, we have significantly expanded the company's development center," says Adi Lev, VP of research and development at DayTwo.
The digital health tech industry will in the next decade be at least a global growth engine like the cyber industry in the previous decade, and no less important, we get to see the direct connection between working in the development center and the impact on user health. When you use the state of Michigan in the USA, you say this week that you have canceled a complex operation to shorten the stomach, or when a user stops using insulin and balances the diabetes, it gives a real sense of meaning and added value to what we do. In addition, Dato has a unique and largest database of its kind in the world, which includes medical, nutritional, behavioral information and deep genetic flooring of the intestinal bacteria of tens of thousands of people. The raising of capital will continue to deepen research into the links between bacteria in our body and other diseases, and to develop new algorithms based on the database in order to produce more significant personal insights that have a proven medical impact. "
The current round of investment comes after the company introduced a significant clinical impact to DayTwo program participants in the US, including improved blood sugar levels and a significant reduction in costs. Following this, impressive deals were signed with large employers, health systems and leading insurance companies in the United States, including one of the three largest insurance companies in the United States. Launch cooperation with Maccabi Health Services.
According to Leah Segal, CEO and Founder of DayTwo: "In the past year, we have been investing most of our efforts and focus on the US market. It is very important to show the clinical impact and improvement of the health of the insured, but also cost savings of those who pay the medical expenses, such as the employer or the insurance company. A healthy person costs the system about $ 6,000 a year, while a person with a metabolic disease can cost four times as much. Our product allows for a significant and rapid reduction in health costs due to decreased drug consumption, doctor visits, complex surgeries, and complications associated with diabetes and metabolic diseases, hence our success in the United States. We will continue to invest resources, grow the development center in the country and bring in experts who are experts in their field in order to deepen the field of intestinal bacterial research and continue to develop products that produce a real clinical impact. "
According to Dr. Yair Schindel, co-founder and CEO of the aMoon Foundation, "DayTwo's ability to remotely access customized medicine using an artificial intelligence-based algorithm will continue to positively impact the world of medicine in general and the world of diabetes and metabolic diseases in particular. Of the company in the global markets "


ABOUT IFI TODAY

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum

Newsline

Former Democratic Senator Joe Lieberman Passes Away at 82 - fell at home

Mar 28, 2024 by Ifi Reporter

The political arena mourns the loss of former Democratic Senator Joe Lieberman, who passed away yesterday at the age of 82. Lieberman, a trailblazer in American politics, made history as the first religious Jewish senator in US history. He leaves behind a legacy marked by his unwavering... Continue reading →

Terrorist Attack Targets Civilians on Route 90 Near Oja in the Jordan valley

Mar 28, 2024 by Ifi Reporter

In a harrowing incident earlier this morning, a shooting attack rocked Route 90 near Oja in the Jordan valley. According to initial reports, a terrorist ambushed a passing bus in the area, unleashing a barrage of gunfire before fleeing the scene. The attack, believed to be premeditated, left a... Continue reading →

Nationwide High School Strike Declared in Israel Amidst Salary Dispute

Mar 27, 2024 by Ifi Reporter

The National Student and Youth Council, alongside parent leaders, issued a stern announcement on Wednesday, declaring a strike in all high schools across Israel starting Thursday. This drastic action follows the failure of negotiations between the teachers' organization and the Ministry of... Continue reading →


Testimonials

No testimonials. Click here to add your testimonials.